Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

AAH cites 'competitive' wholesale market for failure to secure Glutafin

AAH still offers its customers a "compelling" range of services to manufacturers and its downstream customers despite losing the solus distribution partnership with Glutafin says Celesio pharmaco director Stuart Lucas

EXCLUSIVE

AAH Pharmaceuticals has admitted it was "disappointed" to lose out on the sole distribution rights of Glutafin products to Alliance Healthcare.


Stuart Lucas, pharmaco director of AAH parent company Celesio UK, said the "very competitive" wholesale sector was to blame for its failure to secure the deal, which will see Alliance Healthcare become the exclusive distributor of the gluten-free products from Wednesday (October 1).


However, AAH remained positive that it still offered both manufacturers and pharmacists a "compelling" range of services, Mr Lucas told C+D in an exclusive interview last Thursday (September 25). 


At "any point in time", wholesalers were likely to be in discussions about potential changes to distribution arrangements to suit manufacturers' needs, Mr Lucas said.


AAH's strong position was demonstrated by its announcement last month that it had secured the rights to solely distribute products from manufacturer MSD, the sixth deal of its kind for the wholesaler in the past year, he added.


Announcing its deal with Glutafin last week (September 23), Alliance Healthcare said the arrangement should "streamline the ordering process" for pharmacists. Glutafin products would arrive as part of a pharmacy's usual Alliance Healthcare delivery and would not be subject to any surcharges if purchased in isolation, it added.


In April, Celesio predicted a growth in exclusive wholesaling deals as manufacturers put more products out to tender.


The previous month, PSNC warned that AAH's exclusive deal with Archimedes, following similar distribution arrangements by other manufacturers, would "further reduce competition in the wholesaler market". 



What effect could exclusive distribution deals have on your business? 

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Topics



Pharmacist Managers - Recruiting Now !
East London, Essex and Luton
£40,000 - £50,000 per year

Apply Now
UsernamePublicRestriction

Register

CD017299

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel